Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: J Clin Lipidol. 2017 Dec 27;12(2):481–487.e14. doi: 10.1016/j.jacl.2017.12.007

Table 3.

Association between lipoproteins and cardiovascular hospitalization or mortality

Univariate models Multivariable models
Variable HR (95% CI) P-value HR (95% CI) P-value
Apo A1, per 10 mg/dL 0.93 (0.84, 1.02) 0.11 0.96 (0.87, 1.06) 0.39
Apo B, per 10 mg/dL 0.90 (0.79, 1.04) 0.15 0.92 (0.80, 1.06) 0.27
Apo C2, per mg/dL 0.94 (0.84, 1.06) 0.31 0.95 (0.85, 1.06) 0.35
Apo C3, per mg/dL 0.98 (0.93, 1.04) 0.59 0.99 (0.93, 1.05) 0.68
HDL, per 10 mg/dL 0.94 (0.80, 1.12) 0.51 0.96 (0.80, 1.16) 0.68
LDL, per 10 mg/dL 0.90 (0.77, 1.05) 0.19 0.93 (0.80, 1.07) 0.31
Log TG, per mg/dL 0.89 (0.44, 1.47) 0.66 0.95 (0.61, 1.48) 0.83
*

Each multivariable model includes the lipoprotein of interest and is adjusted for age, sex, race, body mass index, diabetes, heart failure, dialysis catheter, serum albumin and log CRP.

Apolipoprotein A1 (Apo A 1), apolipoprotein B (Apo B), apolipoprotein C2 (Apo C2), Apolipoprotein C2 (Apo C3), high density lipoprotein (HDL), low density lipoprotein (LDL), triglyceride (TG).